Literature DB >> 17980150

Molecular modeling of the human multidrug resistance protein 1 (MRP1/ABCC1).

Marianne K DeGorter1, Gwenaëlle Conseil, Roger G Deeley, Robert L Campbell, Susan P C Cole.   

Abstract

Multidrug resistance protein 1 (MRP1/ABCC1) is a 190kDa member of the ATP-binding cassette (ABC) superfamily of transmembrane transporters that is clinically relevant for its ability to confer multidrug resistance by actively effluxing anticancer drugs. Knowledge of the atomic structure of MRP1 is needed to elucidate its transport mechanism, but only low resolution structural data are currently available. Consequently, comparative modeling has been used to generate models of human MRP1 based on the crystal structure of the ABC transporter Sav1866 from Staphylococcus aureus. In these Sav1866-based models, the arrangement of transmembrane helices differs strikingly from earlier models of MRP1 based on the structure of the bacterial lipid transporter MsbA, both with respect to packing of the twelve helices and their interactions with the nucleotide binding domains. The functional importance of Tyr324 in transmembrane helix 6 predicted to project into the substrate translocation pathway was investigated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17980150     DOI: 10.1016/j.bbrc.2007.10.141

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Toward understanding the mechanism of action of the yeast multidrug resistance transporter Pdr5p: a molecular modeling study.

Authors:  Robert M Rutledge; Lothar Esser; Jichun Ma; Di Xia
Journal:  J Struct Biol       Date:  2010-10-27       Impact factor: 2.867

Review 2.  Multidrug Resistance Proteins (MRPs) and Cancer Therapy.

Authors:  Yun-Kai Zhang; Yi-Jun Wang; Pranav Gupta; Zhe-Sheng Chen
Journal:  AAPS J       Date:  2015-04-04       Impact factor: 4.009

3.  The role of multidrug resistance protein (MRP-1) as an active efflux transporter on blood-brain barrier (BBB) permeability.

Authors:  Karthik Lingineni; Vilas Belekar; Sujit R Tangadpalliwar; Prabha Garg
Journal:  Mol Divers       Date:  2017-01-03       Impact factor: 2.943

4.  Transverse and tangential orientation of predicted transmembrane fragments 4 and 10 from the human multidrug resistance protein (hMRP1/ABCC1) in membrane mimics.

Authors:  Béatrice de Foresta; Michel Vincent; Manuel Garrigos; Jacques Gallay
Journal:  Eur Biophys J       Date:  2011-06-24       Impact factor: 1.733

5.  Expression and function of human MRP1 (ABCC1) is dependent on amino acids in cytoplasmic loop 5 and its interface with nucleotide binding domain 2.

Authors:  Surtaj H Iram; Susan P C Cole
Journal:  J Biol Chem       Date:  2010-12-20       Impact factor: 5.157

6.  Mutation of Glu521 or Glu535 in cytoplasmic loop 5 causes differential misfolding in multiple domains of multidrug and organic anion transporter MRP1 (ABCC1).

Authors:  Surtaj H Iram; Susan P C Cole
Journal:  J Biol Chem       Date:  2012-01-09       Impact factor: 5.157

Review 7.  Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms.

Authors:  Qiaoli Li; Qiujie Jiang; Ellen Pfendner; András Váradi; Jouni Uitto
Journal:  Exp Dermatol       Date:  2008-10-22       Impact factor: 3.960

8.  Characterization and analyses of multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphisms in Chinese population.

Authors:  Ji-Ye Yin; Qiong Huang; Youyun Yang; Jian-Ting Zhang; Mei-Zuo Zhong; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Pharmacogenet Genomics       Date:  2009-03       Impact factor: 2.089

Review 9.  Multidrug resistance protein 1 (MRP1, ABCC1), a "multitasking" ATP-binding cassette (ABC) transporter.

Authors:  Susan P C Cole
Journal:  J Biol Chem       Date:  2014-10-03       Impact factor: 5.157

10.  Modulation of the ATPase and transport activities of broad-acting multidrug resistance factor ABCC10 (MRP7).

Authors:  Ekaterina V Malofeeva; Natalya Domanitskaya; Mariya Gudima; Elizabeth A Hopper-Borge
Journal:  Cancer Res       Date:  2012-10-19       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.